tiprankstipranks
Analyst Profile
Followed by 46 other investors
.
Paul Knight

Paul Knight

KeyBanc
Wall Street Analyst
Ranked #1,789 out of 8,054 Analysts on TipRanks (#3,253 out of 21,594 overall experts)

Success Rate

52%
55 out of 106 Profitable Transactions

Average Return

8.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Paul Knight's ratings since 2013 and opened each position for the duration of 1 Year:
51.89% of your transactions would have been profitable with an average return of 8.5%

Stock Rating Distribution

162Ratings
64.81% Buy
33.33% Hold
1.85% Sell
Distribution of Paul Knight's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
BioLife Solutions Inc
(BLFS)
Rating Type:Buy
Dates:Jul 05, 2017 - Jul 05, 2018
Gain:474.80%
The most profitable rating made by Paul Knight

Paul Knight's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
SIAL
Sigma-Aldrich Corp
Aug 15, 2013
Buy
Initiated
100%
+22.80%
1
Mettler-Toledo
Aug 15, 2013
Hold
Initiated
$255.00
(-81.23% Downside)
0.00%
1
Safeguard Scientifics
Aug 15, 2013
Hold
Initiated
$18.00
(346.65% Upside)
0.00%
1
Qiagen
Aug 15, 2013
Hold
Initiated
$24.00
(-49.36% Downside)
0.00%
1
National Instruments
Aug 15, 2013
Hold
Initiated
$33.00
(-23.09% Downside)
0.00%
1
~PLL
Pall Corp
Sep 19, 2013
Buy
Upgraded
100%
+9.90%
2
WX
WuXi PharmaTech
Nov 13, 2013
Hold
Assigned
0.00%
2
Neogen
Dec 19, 2013
Hold
Assigned
$46.00
(117.91% Upside)
0.00%
2
Plug Power
May 05, 2014
Buy
Upgraded
0%
-40.30%
1
IDEX
Jul 24, 2014
Hold
Downgraded
$85.00
(-60.94% Downside)
100%
+32.90%
2
List of latest recommendations made by Paul Knight. Click to expand and see Paul Knight's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More